Haematological symptoms often appear first and include: Fatigue and weakness due to anaemia Pallor (pale skin) Shortness of breath, particularly on exertion Heart palpitations Glossitis (sore, red tongue) Mouth ulcers Neurological manifestations can be particularly concerning and may include: Paraesthesia (pins and needles) in hands and feet Peripheral neuropathy causing numbness or altered sensation Difficulty walking or balance problems (ataxia) Memory problems and cognitive difficulties Mood changes, including depression or irritability Rare optic neuropathy in severe cases Other symptoms that may occur include: Digestive disturbances Loss of appetite and weight loss Generalised weakness It is crucial to note that neurological symptoms can occur even in the absence of anaemia, and you should contact your GP urgently if you experience persistent paraesthesia, balance problems, memory difficulties, or unexplained neurological symptoms
Preclinical data suggests that even when administered in a location far from the injury site, BPC-157 can travel through the bloodstream and exert its regenerative effects wherever damage is present
Whether this translates to human outcomes at typical capsule doses of 250-500 mcg has not been confirmed in a controlled human trial
For systemic effects, the abdomen is standard
[8] No serious systemic events attributable to topical GHK-Cu have been documented in the literature to date, yet comprehensive long-term surveillance data are still limited
5-amino-1mq tablets are an oral dosage form of selective NNMT inhibitors
